Crosswalk Therapeutics
Biotechnology Research • • 11-20 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 11-20 |
Key Contacts at Crosswalk Therapeutics
Madhu Natarajan
Chief Executive Officer
Natalia Boukharov
Senior Director, Drug Development
Roshan Padmashali
Senior Director
Wanida Ruangsiriluk
Associate Director
Crosswalk Therapeutics Email Formats
Crosswalk Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@crosswalktx.com), used 94.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@crosswalktx.com | 94.4% |
{first name} | john@crosswalktx.com | 5.6% |
About Crosswalk Therapeutics
We relentlessly pursue functional cures for rare diseases patients and their families.
Crosswalk Therapeutics revenue & valuation
| Annual revenue | $1,197,770 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,900,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Crosswalk Therapeutics has 2 employees across 2 departments.
Departments
Number of employees
Funding Data
Crosswalk Therapeutics has never raised funding before.
Crosswalk Therapeutics Tech Stack
Discover the technologies and tools that power Crosswalk Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Hosting
CMS
Miscellaneous
Security
JavaScript frameworks
JavaScript frameworks
Miscellaneous
United Kingdom
Israel
Slovenia
Virgin Islands, U.S.
NetherlandsFrequently asked questions
4.8
40,000 users
